217099-10-0Relevant articles and documents
Axially chiral 1,7-naphthyridine-6-carboxamide derivatives as orally active tachykinin NK1 receptor antagonists: Synthesis, antagonistic activity, and effects on bladder functions
Natsugari, Hideaki,Ikeura, Yoshinori,Kamo, Izumi,Ishimaru, Takenori,Ishichi, Yuji,Fujishima, Akira,Tanaka, Toshimasa,Kasahara, Fumiko,Kawada, Mitsuru,Doi, Takayuki
, p. 3982 - 3993 (2007/10/03)
Cyclic analogues of N-[3,5-bis(trifluoromethyl)benzyl]-7,8-dihydro-N,7- dimethyl-5-(4-methylphenyl)-8-oxo-1,7-naphthyridine-6-carboxamide (1) having a 6-9-membered ring (6-9) were synthesized and evaluated for NK1 antagonistic activities. The 8
Enantioselective synthesis of an axially chiral 1,7-naphthyridine-6-carboxamide derivative having potent antagonist activity at the NK1 receptor
Ikeura, Yoshinori,Ishimaru, Takenori,Doi, Takayuki,Kawada, Mitsuru,Fujishima, Akira,Natsugari, Hideaki
, p. 2141 - 2142 (2007/10/03)
A new and highly potent NK1 antagonist, (aR,9R)-3 [(aR,9R)-7-[3,5-bis(trifluoromethyl)benzyl]-8,9,10,11-tetrahydro-9-methyl-5-(4- methylphenyl)-7H-[1,4]diazocino[2,1-g][1,7]naphthyridine-6,13-dione], was atropdiastereoselectively synthesized in